Replies to post #42769 on Cytodyn Inc (CYDY)

[Evil Rabbit]

Agreed. I hope Nader isn’t counting in TNBC injection to blow the doors of this second TO. It’ll need bigger milestones to get more folks converting.

[I_luv_cydy]

Does it really cost CYDY anything to re-open the TO for another 20 business days (that's the rule...regardless of the daily fluctuations of the stock price)?
I'm hoping more news comes out to convince those warrant holders that are on the fence. If this latest TO bombs, then what is our next financing option? Nader talks as if there is no more reason to go back to the old dilutive raises with warrants.

[penniestodimes]

Agree 100%, and I stated the same thoughts here a couple weeks ago. IMO, I’m going to go with next week, the PR’s start rolling out, and my first guess is 1st patient injected for TNBC study. Then hopefully some sort of licensing deal or partnerships.

[finesand]

I am really holding back with my negative opinion here.

ASM Microbe June 20-24th is done and we got: Nothing.

They now managed to fail all 2Q19 milestones as well.
(There was a nice long list posted here)

I agree, if nothing very hopeful is coming,
CYDY is running risk of being re-evaluated
and they actually gave out their own same
price target for the second time.
But next milestones in 4Q19 would drive the price even lower.

Some other not so nicely sounding attributes are already floating around. I will hold back my breath here, the company needs to fix this mess, instead of trapping folks with the NASH honeypot.

NASH + Inflection Point fairy tales, those Märchen won't help for too long while burning cash w/o progress and having no better source of income, but TO at 26.667c per shares.

Next 10-Q will also give a first notion of the current cash burn, having RP's company combined and the new Florida offices.
Increased costs but reduced output.

Stockholder are still positive, just a slow slide so far.

Yes, this is all my opinion.